Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

General characteristics of the sample.

More »

Table 1 Expand

Fig 1.

(A). ROC Curves and Area Under Curve (AUC) for DIABSCORE for detecting prevalence of undiagnosed diabetes according to fasting blood glucose ≥ 126 mg/dL, in participants aged 18–75 yr. AUC = 0.62 (0.53–0.72). (B). ROC Curves and Area Under Curve (AUC) for DIABSCORE for detecting prevalence of undiagnosed prediabetes according to ADA criteria (Blood glucose ≥100 and ≤125mg/dL), in participants aged 18–75 yr. AUC = 0.57 (0.49–0.65).

More »

Fig 1 Expand

Fig 2.

(A). ROC Curves and Area Under Curve (AUC) for DIABSCORE for detecting prevalence of undiagnosed diabetes according to fasting blood glucose ≥ 126 mg/dL, in participants aged 18–54 yr. AUC = 0.61 (0.49–0.73). (B). ROC Curves and Area Under Curve (AUC) for DIABSCORE for detecting prevalence of undiagnosed prediabetes according to ADA criteria (Blood glucose ≥100 and ≤125mg/dL), in participants aged 18–54 yr. AUC = 0.62 (0.51–0.72).

More »

Fig 2 Expand

Table 2.

Sensitivity, specificity, predictive values and likelihood ratios of DIABSCORE cut-off points in participants aged 18–75 yr.

More »

Table 2 Expand

Table 3.

Sensitivity, specificity, predictive values and likelihood ratios of DIABSCORE cut-off points in participants aged 18–54 yr.

More »

Table 3 Expand

Table 4.

Prevalences odds ratios (OR) and 95% CI among participants aged 18–75 years exposed or not exposed to: DIABSCORE value ≥ 80 or DIABSCORE value ≥ 90 or prediabetes (blood glucose ≥100 and ≤125mg/dL) or type 2 diabetes (blood glucose ≥126 mg/dL).

More »

Table 4 Expand

Table 5.

Prevalences odds ratios (OR) and 95% CI among participants aged 18–54 years exposed or not exposed to: DIABSCORE value ≥ 80 or DIABSCORE value ≥90 or prediabetes (blood glucose ≥100 and ≤125mg/dL) or type 2 diabetes (blood glucose ≥126 mg/dL).

More »

Table 5 Expand